129 related articles for article (PubMed ID: 36054271)
1. Bone morphogenetic protein pathway responses and alterations of osteogenesis in metastatic prostate cancers.
Provera MD; Straign DM; Karimpour P; Ihle CL; Owens P
Cancer Rep (Hoboken); 2023 Feb; 6(2):e1707. PubMed ID: 36054271
[TBL] [Abstract][Full Text] [Related]
2. Targeting the BMP Pathway in Prostate Cancer Induced Bone Disease.
Straign DM; Ihle CL; Provera MD; Owens P
Front Endocrinol (Lausanne); 2021; 12():769316. PubMed ID: 34956082
[TBL] [Abstract][Full Text] [Related]
3. Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer.
Feeley BT; Gamradt SC; Hsu WK; Liu N; Krenek L; Robbins P; Huard J; Lieberman JR
J Bone Miner Res; 2005 Dec; 20(12):2189-99. PubMed ID: 16294272
[TBL] [Abstract][Full Text] [Related]
4. Combined inhibition of the BMP pathway and the RANK-RANKL axis in a mixed lytic/blastic prostate cancer lesion.
Virk MS; Alaee F; Petrigliano FA; Sugiyama O; Chatziioannou AF; Stout D; Dougall WC; Lieberman JR
Bone; 2011 Mar; 48(3):578-87. PubMed ID: 21073986
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of bone morphogenetic protein-7 in bone metastatic prostate cancer.
Masuda H; Fukabori Y; Nakano K; Takezawa Y; CSuzuki T; Yamanaka H
Prostate; 2003 Mar; 54(4):268-74. PubMed ID: 12539225
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of noggin inhibits BMP-mediated growth of osteolytic prostate cancer lesions.
Feeley BT; Krenek L; Liu N; Hsu WK; Gamradt SC; Schwarz EM; Huard J; Lieberman JR
Bone; 2006 Feb; 38(2):154-66. PubMed ID: 16126463
[TBL] [Abstract][Full Text] [Related]
7. Role of bone morphogenetic proteins in human prostate cancer pathogenesis and development of bone metastases: immunohistochemical study.
Spanjol J; Djordjević G; Markić D; Klarić M; Fuckar D; Bobinac D
Coll Antropol; 2010 Apr; 34 Suppl 2():119-25. PubMed ID: 21302710
[TBL] [Abstract][Full Text] [Related]
8. BMP3: to be or not to be a BMP.
Bahamonde ME; Lyons KM
J Bone Joint Surg Am; 2001; 83-A Suppl 1(Pt 1):S56-62. PubMed ID: 11263666
[TBL] [Abstract][Full Text] [Related]
9. Bone morphogenetic protein-6 expression in normal and malignant prostate.
Barnes J; Anthony CT; Wall N; Steiner MS
World J Urol; 1995; 13(6):337-43. PubMed ID: 9116752
[TBL] [Abstract][Full Text] [Related]
10. A comprehensive expression survey of bone morphogenetic proteins in breast cancer highlights the importance of BMP4 and BMP7.
Alarmo EL; Kuukasjärvi T; Karhu R; Kallioniemi A
Breast Cancer Res Treat; 2007 Jun; 103(2):239-46. PubMed ID: 17004110
[TBL] [Abstract][Full Text] [Related]
11. Bone morphogenetic protein 7 is expressed in prostate cancer metastases and its effects on prostate tumor cells depend on cell phenotype and the tumor microenvironment.
Morrissey C; Brown LG; Pitts TE; Vessella RL; Corey E
Neoplasia; 2010 Feb; 12(2):192-205. PubMed ID: 20126477
[TBL] [Abstract][Full Text] [Related]
12. Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs).
Cheng H; Jiang W; Phillips FM; Haydon RC; Peng Y; Zhou L; Luu HH; An N; Breyer B; Vanichakarn P; Szatkowski JP; Park JY; He TC
J Bone Joint Surg Am; 2003 Aug; 85(8):1544-52. PubMed ID: 12925636
[TBL] [Abstract][Full Text] [Related]
13. Expression of bone morphogenetic proteins in human metastatic prostate and breast cancer.
Bobinac D; Marić I; Zoricić S; Spanjol J; Dordević G; Mustać E; Fuckar Z
Croat Med J; 2005 Jun; 46(3):389-96. PubMed ID: 15861517
[TBL] [Abstract][Full Text] [Related]
14. Expression of bone morphogenetic protein messenger RNAs by normal rat and human prostate and prostate cancer cells.
Harris SE; Harris MA; Mahy P; Wozney J; Feng JQ; Mundy GR
Prostate; 1994 Apr; 24(4):204-11. PubMed ID: 8146069
[TBL] [Abstract][Full Text] [Related]
15. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional characterization of bone morphogenetic proteins (BMPs)-mediated osteogenic signaling.
Peng Y; Kang Q; Cheng H; Li X; Sun MH; Jiang W; Luu HH; Park JY; Haydon RC; He TC
J Cell Biochem; 2003 Dec; 90(6):1149-65. PubMed ID: 14635189
[TBL] [Abstract][Full Text] [Related]
17. Bone morphogenetic proteins.
Chen D; Zhao M; Mundy GR
Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
[TBL] [Abstract][Full Text] [Related]
18. Bone Cell Activity in Clinical Prostate Cancer Bone Metastasis and Its Inverse Relation to Tumor Cell Androgen Receptor Activity.
Nordstrand A; Bovinder Ylitalo E; Thysell E; Jernberg E; Crnalic S; Widmark A; Bergh A; Lerner UH; Wikström P
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29670000
[TBL] [Abstract][Full Text] [Related]
19. Immunolocalization and messenger RNA expression of bone morphogenetic protein-6 in human benign and malignant prostatic tissue.
Hamdy FC; Autzen P; Robinson MC; Horne CH; Neal DE; Robson CN
Cancer Res; 1997 Oct; 57(19):4427-31. PubMed ID: 9331107
[TBL] [Abstract][Full Text] [Related]
20. Contextual effect of repression of bone morphogenetic protein activity in prostate cancer.
Pham LK; Liang M; Adisetiyo HA; Liao CP; Cohen MB; Tahara SM; Frenkel B; Kasahara N; Roy-Burman P
Endocr Relat Cancer; 2013 Dec; 20(6):861-74. PubMed ID: 24042462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]